TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 27 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,661,000 | – | 170,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Puissance Capital Management LP | 4,601,768 | $2,899,000 | 3.31% |
| Telemetry Investments, L.L.C. | 966,975 | $609,000 | 0.39% |
| 683 Capital Management, LLC | 2,738,938 | $1,726,000 | 0.10% |
| Anson Funds Management LP | 250,182 | $158,000 | 0.09% |
| NEA Management Company, LLC | 3,467,181 | $2,184,000 | 0.09% |
| LINDEN ADVISORS LP | 2,842,477 | $1,791,000 | 0.05% |
| X-Square Capital, LLC | 79,198 | $50,000 | 0.04% |
| QVT Financial LP | 23,351 | $15,000 | 0.01% |
| BHK Investment Advisors, LLC | 10,000 | $6,000 | 0.01% |
| Virtu Financial LLC | 18,233 | $11,000 | 0.00% |